`
`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`______________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`______________
`
`
`
`TEVA PHARMACEUTICALS USA, INC.,
`Petitioner,
`
`v.
`
`MONOSOL RX, LLC,
`Patent Owner.
`______________
`
`
`
`Case IPR2016-00281
`Patent 8,603,514 B2
`______________
`
`
`PETITIONER’S UPDATED EXHIBIT LIST
`
`
`
`
`
`
`
`
`
`
`
`
`
`Pursuant to 37 C.F.R. § 42.63(e), Petitioner submits the following current
`
`exhibit list:
`
`Exhibit No.
`
`1001
`
`1002
`
`1003
`
`1004
`
`1005
`
`1006
`
`1007
`
`1008
`
`1009
`
`1010
`
`1011
`
`1012
`
`1013
`
`1014
`
`Description
`
`U.S. Patent No. 8,603,514 (filed July 10, 2007)
`
`File History, U.S. Patent No. 8,603,514
`
`Expert Declaration of Jayanth Panyam, Ph.D., Relating to U.S.
`Patent No. 8,603,514
`U.S. Patent No. 7,067,116 (filed Mar. 23, 2000) (“Bess”)
`
`WO 00/42992 (published July 27, 2000) (“Chen”)
`
`CA 2,274,910 (published June 25, 1998) (“Cremer”)
`
`File History of Reexam No. 95/002,170
`
`Alfred Martin, Physical Pharmacy (4th ed. 1993) (“Physical
`Pharmacy”)
`Joint Claim Construction Chart, Reckitt Benckiser Inc. v. Teva
`Pharmaceutical USA, Inc., CA. No. 14-01451-RGA (Nov. 17,
`2015), D.I. 91
`Trial Transcript, Reckitt Benckiser Inc. v. Watson Labs., Inc.,
`CA No. 14-1574-RGA (Nov. 3-4, 2015) (“Trial Tr.”)
`U.S. Patent No. 6,221,402 (issued April 24, 2001)
`
`C.S. Fuller et al., Interactions in poly(ethylene oxide)—
`hydroxypropyl methylcellulose blends, 42 Polymer 9583
`(2001)
`Leon Lachman et al, The Theory and Practice of Industrial
`Pharmacy (1986) (“The Theory and Practice of Industrial
`Pharmacy”)
`J. Thuro Carstensen, Theory of Pharmaceutical Systems
`Volume II: Heterogenous Systems (1973) (“Theory of
`Pharmaceutical Systems”)
`
`
`
`
`2
`
`
`
`
`
`
`
`
`1015
`
`1016
`
`1017
`
`1018
`
`1019
`
`1020
`
`1021
`
`1022
`
`1023
`
`1024
`
`1025
`
`1026
`
`1027
`
`1028
`
`1029
`
`1030
`
`1031
`
`Remington’s Pharmaceutical Sciences (Alfonso R. Gennaro,
`ed., 18th ed., 1990)
`Mixing in the Process Industries (N. Harnby et al., eds., 2nd
`ed., 1997)
`Sevim Kaya & Ahmet Kaya, Microwave drying effects on
`properties of whey protein isolate edible films, 43 Journal of
`Food Engineering 91 (2000)
`X.Z. Shu et al., Novel pH-sensitive citrate cross-linked chitosan
`film for drug controlled release, 212 International Journal of
`Pharmaceutics 19 (2001)
`T.J. Bowser & L.R. Wilhelm, Modeling Simultaneous
`Shrinkage and Heat and Mass Transfer of a Thin, Nonporous
`Film During Drying, Vol. 60 No. 4 Journal of Food Science
`753 (Nov. 4, 1995)
`U.S. Patent No. 6,596,298 (filed September 14, 1999)
`
`U.S. Patent No. 6,099,865 (filed June 11, 1999)
`
`U.S. Patent No. 5,166,233 (filed January 31, 1990)
`
`Jian-Hwa Guo & Horst Zerbe, Water Soluble Film for Oral
`Administration, The 24th International Symposium on
`Controlled Release of Bioactive Materials 227 (1997) (“Guo”)
`J.P. Cassidy et al., Controlled buccal delivery of
`buprenorphine, 25 Journal of Controlled Release 21 (1993)
`U.S. Patent No. 4,849,246 (issued July 18, 1989)
`
`U.S. Patent No. 5,393,528 (filed June 1, 1993)
`
`U.S. Patent No. 5,948,430 (filed August 1, 1997) (“Zerbe”)
`
`U.S. Patent No. 5,629,003 (filed September 2, 1994)
`
`EP No. 0,090,560 (published May 3, 1989) (“Mitra”)
`
`Remington’s Pharmaceutical Sciences (John E. Hoover ed.,
`15th ed. 1975)
`Arlene Weintraub, It's On The Tip Of Your Tongue,
`
`3
`
`
`
`
`
`
`
`
`1032
`
`1033
`
`1034
`
`1035
`
`1036
`
`1037
`
`1038
`
`1039
`
`1040
`
`1041
`
`1042
`
`1043
`
`1044
`
`1045
`
`1046
`
`Bloomberg (July 30, 2006),
`http://www.bloomberg.com/bw/stories/20060730/
`itsonthetipofyourtongue
`U.S. Patent No. 6,552,024 (filed Nov. 5, 1999)
`
`WO 2001/70194 (published September 27, 2001)
`
`Curriculum Vitae of Jayanth Panyam, Ph.D.
`
`Materials Considered by Jayanth Panyam, Ph.D.
`
`S. Le Person et al., Near Infrared Drying of Pharmaceutical
`Thin Films: Experimental Analysis of Internal Mass Transport,
`37 Chemical Engineering & Processing 257 (1998) (“Le
`Person”)
`Decision on Appeal Regarding U.S. Patent 7,666,337, Appeal
`2014-00893
`Decision on Appeal Regarding U.S. Patent 7,824,588, Appeal
`2014-000547
`Decision on Appeal Regarding U.S. Patent 7,897,080, Appeal
`2014-007671
`Telephone Conference Transcript, Teva Pharmaceuticals USA,
`Inc. v. Monsol RX LLC and Indivior, IPR2016-00280,
`IPR2016-00281, and IPR2016-00282 (Feb. 17, 2016)
`Declaration of Eleanor Yost in Support of Petitioner’s Motion
`to Correct Filing Date, IPR2016-00281, IPR2016-00282
`Declaration of Linda Rogers in Support of Petitioner’s Motion
`to Correct Filing Date, IPR2016-00281, IPR2016-00282
`PRPS System Notification – Petition Submission IPR2016-
`00280
`PRPS System Notification – Payment Receipt IPR2016-00281
`
`PRPS System Notification – Payment Receipt IPR2016-00281
`
`PRPS System Notification – Petition Submission IPR2016-
`00281
`
`4
`
`
`
`1047
`
`1048
`
`1049
`
`1050
`
`1051
`
`1052
`
`1053
`
`1054
`
`1055
`
`1056
`
`1057
`
`1058
`
`PRPS System Notification – Payment Receipt IPR2016-00282
`
`PRPS System Notification – Payment Receipt IPR2016-00282
`
`PRPS System Notification – Payment Receipt IPR2016-00282
`
`PRPS System Notification – Payment Receipt IPR2016-00282
`
`PRPS System Notification – Payment Receipt IPR2016-00282
`
`PRPS System Notification – Petition Submission IPR2016-
`00282
`December 4, 2015 email Yost to Trials@USPTO.gov
`
`FedEx Tracking record
`
`December 4, 2015 email Vignone to Yost
`
`January 22, 2016 email Vignone to Yost
`
`December 10, 2015 email Vignone to Yost
`
`Declaration of Eleanor Yost in Support of Petitioner’s Reply
`
`
`
`5
`
`
`
`
`
`
`
`
`
`
`
`
`CERTIFICATE OF SERVICE
`
`The undersigned hereby certifies that the foregoing: PETITIONER’S
`
`UPDATED EXHIBIT LIST was served electronically via e-mail on March 15,
`
`2016 on the following:
`
`Daniel A. Scola, Jr.
`
`dscola@hbiplaw.com
`
`Michael I. Chakansky
`
`mchakansky@hbiplaw.com
`
`514ipr@hbiplaw.com
`
`By: /Cynthia Lambert Hardman/
` Cynthia Lambert Hardman
`(Reg. No. 53,179)
`
`6
`
`
`Dated: March 15, 2016